Literature DB >> 10870973

Comparative analysis of brain proteins from p53-deficient mice by two-dimensional electrophoresis.

N Araki1, T Morimasa, T Sakai, H Tokuoh, S Yunoue, M Kamo, K Miyazaki, K Abe, H Saya, A Tsugita.   

Abstract

p53 is a tumor suppressor protein that regulates many cellular processes including the cell cycle, DNA repair, and apoptosis. It also serves as a critical regulator of neuronal apoptosis in the central nervous system (CNS). To elucidate the role of p53 in the CNS, brain proteins of p53 knock-out mice (p53-/-) were analyzed by two-dimensional gel electrophoresis (2-DE) and compared with those from p53 wild type (p53+/+) mice. Six types of brain tissue (temporal cortex, cerebellum, hippocampus, striatum, olfactory bulb, and cervical spinal cord) and other control tissues (lung and blood) from 18-week-old non-stress-induced mice were analyzed. The morphology of brains from p53-/- mice appeared to be normal and identical to that of p53+/+ mice, although lungs showed diffuse tumors that may have been caused by p53 deficiency. Comparative 2-D gel analysis showed that, on average, 7 of 886 spots from brain tissue were p53-/- specific, whereas 12 of 1008 spots from lung tissue were p53-/- specific. N-terminal amino acid sequence was determined for p53-/- specific proteins. In all brain tissues from p53-/- mice, a newly identified mouse mitochondrial NADH-ubiquinone oxidoreductase 24 kDa subunit showed decreased expression, and apolipoprotein A1 acidic forms showed increased expression. In addition, brain-type creatine kinase B chain and tubulin beta-5 N-terminal fragment were increased in the p53-/- cerebellum, and a new protein in mouse, hydroxyacylglutathione hydrolase (glyoxalase II) was decreased in the temporal cortex of p53-/- mice. The alterations in protein expression identified in this study may imply a p53-related brain function. This is the first proteomic analysis on the p53-/- mouse brain, and further information based on this study will provide new insights into the p53 function in the CNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10870973     DOI: 10.1002/(SICI)1522-2683(20000501)21:9<1880::AID-ELPS1880>3.0.CO;2-9

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  6 in total

1.  Silencing of CT120 by antisense oligonucleotides could inhibit the lung cancer cells growth.

Authors:  Z Li; S Shao; S Xie; F Jiao; Y Ma; S Shi
Journal:  Ir J Med Sci       Date:  2009-12-20       Impact factor: 1.568

Review 2.  Metabolic Shades of S-D-Lactoylglutathione.

Authors:  Miklós Péter Kalapos; Cinzia Antognelli; Lidia de Bari
Journal:  Antioxidants (Basel)       Date:  2022-05-20

Review 3.  Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense.

Authors:  Ivan A Olovnikov; Julia E Kravchenko; Peter M Chumakov
Journal:  Semin Cancer Biol       Date:  2008-12-03       Impact factor: 15.707

4.  Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects.

Authors:  Mohsen Araghi-Niknam; S Hossein Fatemi
Journal:  Cell Mol Neurobiol       Date:  2003-12       Impact factor: 5.046

5.  Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticus.

Authors:  T Engel; K Tanaka; E M Jimenez-Mateos; A Caballero-Caballero; J H M Prehn; D C Henshall
Journal:  Cell Death Dis       Date:  2010-10-07       Impact factor: 8.469

6.  Proteomic comparison of two-dimensional gel electrophoresis profiles from human lung squamous carcinoma and normal bronchial epithelial tissues.

Authors:  Cui Li; Xianquan Zhan; Maoyu Li; Xiaoying Wu; Feng Li; Jianling Li; Zhiqiang Xiao; Zhuchu Chen; Xueping Feng; Ping Chen; Jingyun Xie; Songping Liang
Journal:  Genomics Proteomics Bioinformatics       Date:  2003-02       Impact factor: 7.691

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.